C5AR1‐induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23784 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Bo Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Cell Proliferation, Toll-Like Receptor 2, Thyroid Carcinoma, Anaplastic, Receptor, Anaphylatoxin C5a. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Hebei Provincial Department of Science and Technology Health Innovation Project, Hebei Province Key Science and Technology Research Program, Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
This study aimed to elucidate the role and mechanisms of Complement C5a receptor 1 (C5AR1) in driving the malignant progression of anaplastic thyroid carcinoma (ATC). C5AR1 expression was assessed in ATC tissues and cell lines. Functional assays evaluated the effects of C5AR1 knockdown on the malignant features of ATC cells. The interaction between C5AR1 and miR‐335‐5p was confirmed using a luciferase reporter assay and Fluorescence in situ hybridization, and the impact of C5AR1 knockdown on the Toll‐like receptor (TLR) 1/2 signaling pathway was examined. In vivo studies evaluated the effects of C5AR1 modulation on tumor growth and metastasis. C5AR1 levels were elevated in ATC tumor samples and associated with poor survival in ATC patients. C5AR1 knockdown impeded ATC cell proliferation, migration, and invasion in vitro. MiR‐335‐5p was identified as an upstream regulator of C5AR1, which negatively modulates C5AR1 expression. C5AR1 knockdown diminished TLR1, TLR2, and myeloid differentiation primary response 88 (MyD88) levels, while C5AR1 overexpression activated this pathway. Blocking TLR1/2 signaling abrogated the oncogenic effects of C5AR1 overexpression. C5AR1 silencing inhibited tumor growth and lung metastasis of ATC cells in nude mice. C5AR1 contributes to ATC tumorigenesis and metastasis by activating the TLR1/2 pathway, and is negatively regulated by miR‐335‐5p. Targeting the miR‐335‐5p/C5AR1/TLR1/2 axis represents a potential therapeutic strategy for ATC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Förderung
- Hebei Provincial Department of Science and Technology Health Innovation Project
- Hebei Province Key Science and Technology Research Program
- Natural Science Foundation of Hebei Province
Zitieren
APA
Liu, B., Sun, Y., Geng, T., Wang, H., Wu, Z., Xu, L., Zhang, M., Niu, X., Zhao, C., Shang, J., & Shang, F. (2024). C5AR1‐induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23784
Vancouver
Liu B, Sun Y, Geng T, Wang H, Wu Z, Xu L, et al. C5AR1‐induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23784
BibTeX
@article{Liu2024,
author = {Liu, Bo and Sun, Yueyao and Geng, Tongyao and Wang, Haobo and Wu, Zhenyu and Xu, Lei and Zhang, Miao and Niu, Xupeng and Zhao, Chenxu and Shang, Jin and Shang, Fangjian},
title = {C5AR1‐induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23784}
}
EUVIMED